KemFine

KemFine was a Finnish business-to-business fine-chemicals manufacturer that supplied active pharmaceutical ingredient intermediates, agrochemical products, and other specialty chemicals to industrial customers. Its operations developed from a multipurpose chemical plant established by the Finnish chemical group Kemira in 1984 within the Kokkola chemical-industry complex. The business was initially known as Kemira Fine Chemicals and combined chemical manufacturing infrastructure with the ability to produce materials for different customers and applications. The company’s principal activities were based in custom synthesis and contract manufacturing rather than consumer-facing branded products. KemFine marketed custom synthesis at production scales of approximately 10 to 100 tons for agrochemical applications. It also manufactured pharmaceutical intermediates under Good Manufacturing Practice requirements associated with the ICH Q7A guideline. This positioned the company within the specialist supply chain serving pharmaceutical and agricultural-chemical producers, whose own products incorporated or further processed the materials supplied by KemFine. KemFine’s reported sites were located in Kokkola, Finland, and Grangemouth, Scotland, while its headquarters were in Helsinki. The geographic footprint gave the business production capabilities in both Finland and the United Kingdom and supported its relationships with international industrial customers. The company reportedly maintained long-term supply agreements with major global agrochemical companies, indicating a business model based on recurring industrial contracts and technical manufacturing relationships rather than retail distribution. A major ownership change occurred in 2004, when Kemira sold the business to the investment company 3i. Following the transaction, 3i expanded the new independent business by acquiring Avecia Fine Chemicals from Zeneca in 2005. Avecia had roots in Imperial Chemical Industries, so the transaction brought additional fine-chemical manufacturing heritage and capabilities into the enlarged operation. The resulting business continued to focus on custom manufacturing and specialized chemical intermediates. In 2011, KemFine Ltd. was acquired by CABB, a German specialty-chemicals company. After the acquisition, KemFine was renamed CABB Oy. As a result, KemFine no longer exists as an independent operating brand or company under its former name. Its historical significance lies in the development of a Finnish fine-chemicals operation from Kemira’s Kokkola facilities, its expansion through private-equity ownership and the Avecia acquisition, and its eventual integration into CABB’s specialty-chemicals organization.

KemFine’s origins date to 1984, when the Finnish chemical conglomerate Kemira established a multipurpose plant within its Kokkola chemical-plant complex. The operation was known as Kemira Fine Chemicals and was designed to manufacture specialized chemical materials for industrial customers. Kokkola became the core of the business’s Finnish production presence, while the company later also operated a site in Grangemouth, Scotland. The business operated in the fine-chemicals and contract-manufacturing segment. Rather than selling finished consumer products, it supplied other companies with active pharmaceutical ingredient intermediates, agrochemical materials, and specialty chemicals. Its custom-synthesis work for agrochemical applications was marketed at volumes of roughly 10 to 100 tons. Pharmaceutical intermediates were produced according to Good Manufacturing Practice requirements associated with the ICH Q7A guideline. The company’s customer base included major international agrochemical companies, with long-term supply agreements forming an important part of its commercial model. In 2004, Kemira sold the business to 3i. The sale separated the operation from its former parent and created the platform for its development as KemFine. In 2005, 3i expanded the newly independent business by acquiring Avecia Fine Chemicals from Zeneca. Avecia itself had historical roots in Imperial Chemical Industries, and its combination with the former Kemira operation added to the enlarged company’s fine-chemicals capabilities and industrial heritage. KemFine was headquartered in Helsinki and maintained manufacturing locations in Kokkola and Grangemouth. Its activities remained focused on specialized business-to-business chemical production, including custom synthesis, pharmaceutical intermediates, agrochemical chemistry, and other specialty materials. The company’s value proposition rested on technical manufacturing expertise, production at industrial scale, compliance with pharmaceutical quality requirements where applicable, and the ability to support long-term customer supply programs. In 2011, CABB, a German specialty-chemicals company, acquired KemFine Ltd. Following the transaction, the company was renamed CABB Oy. This integration ended KemFine’s existence as an independent company and brand. The KemFine name therefore refers primarily to the period between the 2004 divestiture from Kemira and the 2011 CABB acquisition, while its operational history reaches back to Kemira Fine Chemicals and the 1984 establishment of the Kokkola facility.

• 2011

  CABB acquisition and renaming

  [1]KemFineen.wikipedia.org

  CABB acquires KemFine Ltd. and renames the company CABB Oy, ending KemFine’s independent status.

• 2005

  Avecia Fine Chemicals is added

  [1]KemFineen.wikipedia.org

  3i acquires Avecia Fine Chemicals from Zeneca and combines it with the former Kemira fine-chemicals business.

• 2004

  Kemira divests the business to 3i

  [1]KemFineen.wikipedia.org

  Kemira sells its fine-chemicals operation to investment company 3i, separating it from the Kemira group.

• 1984

  Kemira establishes the Kokkola fine-chemicals operation

  [1]KemFineen.wikipedia.org

  Kemira erects a multipurpose plant in its Kokkola chemical complex. The division operates as Kemira Fine Chemicals and forms the foundation of the later KemFine business.

A business-to-business custom fine-chemicals manufacturer focused on technically demanding intermediates, contract synthesis, and recurring supply relationships with pharmaceutical and agrochemical companies.

• Pharmaceutical chemicals

  Pharmaceutical intermediates

  KemFine manufactured intermediates used in pharmaceutical production. These materials were produced for industrial customers rather than sold as finished medicines, and the company described this activity as being conducted according to Good Manufacturing Practice requirements associated with the ICH Q7A guideline.

• Agrochemical manufacturing

  Agrochemical custom synthesis

  The company provided custom-synthesis and contract-manufacturing services for agrochemical customers, with cited production scales ranging from approximately 10 to 100 tons. These products were supplied to other companies, including major global agrochemical businesses, under long-term commercial relationships.

• Specialty chemicals

  Specialty chemicals

  KemFine’s broader portfolio included specialty chemicals made for industrial customers. The available reference material does not identify individual product names, but places these materials within the company’s custom-manufacturing and fine-chemicals activities.

• 2011

  Acquisition by CABBM&A

  Background

  KemFine operated as a specialist fine-chemicals manufacturer with sites in Finland and Scotland.

  Action taken

  German specialty-chemicals company CABB acquired KemFine Ltd.

  Aftermath

  The company was renamed CABB Oy, and KemFine ceased to operate as an independent corporate brand.

  Source

• 2005

  Acquisition of Avecia Fine ChemicalsM&A

  Background

  After acquiring the former Kemira fine-chemicals business, 3i sought to expand the operation’s capabilities and scale.

  Action taken

  3i acquired Avecia Fine Chemicals from Zeneca and merged it into the enlarged fine-chemicals business.

  Aftermath

  The combination brought together the former Kemira operation and Avecia Fine Chemicals, whose historical origins included Imperial Chemical Industries.

  Source

• 2004

  Divestiture from KemiraM&A

  Background

  Kemira separated its fine-chemicals operation from the wider chemical group by selling it to 3i.

  Action taken

  3i acquired the business and developed it as an independent fine-chemicals operation that became associated with the KemFine name.

  Aftermath

  The transaction enabled subsequent expansion through the acquisition of Avecia Fine Chemicals in 2005.

  Source

1. 1KemFineen.wikipedia.org